首页> 美国卫生研究院文献>Saudi Pharmaceutical Journal : SPJ >Emulsification/internal gelation as a method for preparation of diclofenac sodium–sodium alginate microparticles
【2h】

Emulsification/internal gelation as a method for preparation of diclofenac sodium–sodium alginate microparticles

机译:乳化/内部凝胶化法制备双氯芬酸海藻酸钠-海藻酸钠微粒

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Emulsification/internal gelation has been suggested as an alternative to extrusion/external gelation in the encapsulation of several compounds including non-steroidal anti-inflammatory drugs such as diclofenac sodium. The objective of the present study was a trial to formulate diclofenac sodium as controlled release microparticles that might be administered once or twice daily. This could be achieved via emulsification/internal gelation technique applying Box-Behnken design to choose these formulae. Box-Behnken design determined fifteen formulae containing specified amounts of the independent variables, which included stirring speed in rpm (X1), drug:polymer ratio (X2) and the surfactant span 80% (X3). The dependent variables studied were cumulative percent release after two hours (Y1), four hours (Y2) and eight hours (Y3). The prepared microparticles were characterized for their production yield, sizes, shapes and morphology, entrapment efficiency and Diclofenac sodium in vitro release as well. The results showed that the production yield of the prepared diclofenac sodium microparticles was found to be between 79.55% and 97.41%. The formulated microparticles exhibited acceptable drug content values that lie in the range 66.20–96.36%. Also, the data obtained revealed that increasing the mixing speed (X1) generally resulted in decreased microparticle size. In addition, scanning electron microscope images of the microparticles illustrated that the formula contains lower span concentration (1%) in combination with lower stirring speed (200 rpm) which showed wrinkled, but smooth surfaces. However, by increasing surfactant concentration, microspheres’ surfaces become smoother and slightly porous. Kinetic treatment of the in vitro release from drug-loaded microparticles indicated that the zero order is the drug release mechanism for the most formulae.
机译:在封装包括非甾体抗炎药例如双氯芬酸钠的几种化合物时,已经提出了乳化/内部凝胶化作为挤出/外部凝胶化的替代方法。本研究的目的是尝试将双氯芬酸钠制成控释微粒,每天两次或两次。这可以通过采用Box-Behnken设计的乳化/内部胶凝技术来选择这些配方来实现。 Box-Behnken设计确定了包含指定量的独立变量的15个配方,其中包括以rpm为单位的搅拌速度(X1),药物:聚合物比(X2)和表面活性剂跨度为80%(X3)。研究的因变量是两个小时(Y1),四个小时(Y2)和八个小时(Y3)后的累积释放百分比。制备的微粒的特征在于其产量,大小,形状和形态,包封率以及双氯芬酸钠的体外释放。结果表明,制得的双氯芬酸钠微粒的产率为79.55%至97.41%。配制的微粒表现出可接受的药物含量值,范围为66.20–96.36%。另外,获得的数据表明增加混合速度(X1)通常导致减小的微粒尺寸。此外,微粒的扫描电子显微镜图像表明该配方包含较低的跨度浓度(1%)和较低的搅拌速度(200 rpm),显示出皱纹但表面光滑。但是,通过增加表面活性剂的浓度,微球的表面变得更光滑,略微多孔。从载药微粒体外释放的动力学处理表明,零级是大多数配方药物的释放机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号